Fed. Circ. Tosses Becton's $58M Syringe Patent Win

Law360, New York (July 29, 2010, 7:27 PM EDT) -- A federal appeals court on Thursday reversed a $58 million jury award Becton Dickinson and Co. had won in an infringement suit against former Tyco International Ltd. subsidiary Covidien PLC over a syringe patent.

In a 2-1 decision, the U.S. Court of Appeals for the Federal Circuit reversed the ruling in Becton's favor that found Covidien's Monoject Magellan syringes infringed a patent.

The U.S. District Court for the District of Delaware incorrectly construed the “spring means” limitation of the asserted claims and erred in denying a...
To view the full article, register now.